Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “H7N9 Influenza Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00776711
What this trial is testing

Vaccine for Prevention of Bird Flu

Who this might be right for
Influenza, Human
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT01658800
What this trial is testing

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49

Who this might be right for
Influenza
VaxInnate Corporation 275
Large-scale testing (Phase 3)Study completedNCT01774032
What this trial is testing

H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older

Who this might be right for
Influenza
Alachua Government Services, Inc. 91
Not applicableStudy completedNCT01107262
What this trial is testing

Avian Influenza Studies In Lebanon

Who this might be right for
Avian InfluenzaVirus Diseases
St. Jude Children's Research Hospital 250
Early research (Phase 1)Study completedNCT00660257
What this trial is testing

Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine

Who this might be right for
Pandemic Influenza VaccinePreventionPandemic Influenza
Sinovac Biotech Co., Ltd 57
Large-scale testing (Phase 3)Study completedNCT01310413
What this trial is testing

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 842
Early research (Phase 1)Study completedNCT00382980
What this trial is testing

Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 308
Early research (Phase 1)Study completedNCT02251288
What this trial is testing

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

Who this might be right for
Avian InfluenzaImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 62
Testing effectiveness (Phase 2)Study completedNCT01776541
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 979
Not applicableLooking for participantsNCT06850298
What this trial is testing

H5N1 Milk Detection Study

Who this might be right for
Influenza
Emory University 30
Early research (Phase 1)Study completedNCT01142362
What this trial is testing

Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults

Who this might be right for
Healthy
Inovio Pharmaceuticals 32
Testing effectiveness (Phase 2)Study completedNCT01195038
What this trial is testing

Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults

Who this might be right for
Influenza
UMN Pharma Inc. 87
Early research (Phase 1)Study completedNCT00457509
What this trial is testing

Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic InfluenzaInfluenza A Virus InfectionOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 251
Testing effectiveness (Phase 2)Study completedNCT01942265
What this trial is testing

H7N9 Mix and Match With AS03 and MF59 in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 980
Testing effectiveness (Phase 2)Study completedNCT00296634
What this trial is testing

H5 Vaccine Alone or With Adjuvant in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 600
Early research (Phase 1)UnknownNCT03739229
What this trial is testing

Reactogenicity, Safety and Immunogenicity of a LAIV А/17/Hong Kong/2017/75108 H7N9 Influenza Vaccine

Who this might be right for
Vaccine Adverse Reaction
Research Institute of Influenza, Russia 40
Not applicableStudy completedNCT00311727
What this trial is testing

Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 339
Early research (Phase 1)Study completedNCT02624219
What this trial is testing

H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults

Who this might be right for
Avian InfluenzaInfluenza
National Institute of Allergy and Infectious Diseases (NIAID) 276
Testing effectiveness (Phase 2)Study completedNCT00703053
What this trial is testing

H5N1 Priming and Boosting Strategies

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 505
Large-scale testing (Phase 3)Study completedNCT00841763
What this trial is testing

Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects

Who this might be right for
Pandemic Influenza Disease
Novartis 3,647
Next Page